CZ20012113A3 - Prostředky a způsoby pro léčbu onemocnění anorektální oblasti - Google Patents

Prostředky a způsoby pro léčbu onemocnění anorektální oblasti

Info

Publication number
CZ20012113A3
CZ20012113A3 CZ20012113A CZ20012113A CZ20012113A3 CZ 20012113 A3 CZ20012113 A3 CZ 20012113A3 CZ 20012113 A CZ20012113 A CZ 20012113A CZ 20012113 A CZ20012113 A CZ 20012113A CZ 20012113 A3 CZ20012113 A3 CZ 20012113A3
Authority
CZ
Czechia
Prior art keywords
preparations
methods
treating anorectal
anorectal area
area
Prior art date
Application number
CZ20012113A
Other languages
English (en)
Inventor
Thomas P. Parks
Vivien Mak
Jung-Chung Lee
Charles Lee
Original Assignee
Cellegy Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27381146&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CZ20012113(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cellegy Pharmaceuticals, Inc. filed Critical Cellegy Pharmaceuticals, Inc.
Publication of CZ20012113A3 publication Critical patent/CZ20012113A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ20012113A 1998-12-14 1999-12-13 Prostředky a způsoby pro léčbu onemocnění anorektální oblasti CZ20012113A3 (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11232598P 1998-12-14 1998-12-14
US13991699P 1999-06-17 1999-06-17
US15531899P 1999-09-21 1999-09-21

Publications (1)

Publication Number Publication Date
CZ20012113A3 true CZ20012113A3 (cs) 2001-11-14

Family

ID=27381146

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20012113A CZ20012113A3 (cs) 1998-12-14 1999-12-13 Prostředky a způsoby pro léčbu onemocnění anorektální oblasti

Country Status (14)

Country Link
US (2) US6395736B1 (cs)
EP (1) EP1143956A3 (cs)
JP (1) JP2002542147A (cs)
KR (1) KR20010093828A (cs)
CN (2) CN1526448A (cs)
AU (1) AU764921B2 (cs)
BR (1) BR9916162A (cs)
CA (1) CA2354543A1 (cs)
CZ (1) CZ20012113A3 (cs)
HU (1) HUP0104676A3 (cs)
IL (1) IL143726A0 (cs)
NO (1) NO20012916L (cs)
PL (1) PL348817A1 (cs)
WO (1) WO2000035434A2 (cs)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
US6627632B2 (en) * 1998-12-14 2003-09-30 Cellegy Pharmaceuticals, Inc. Compositions and methods for the treatment of anorectal disorders
GB9924636D0 (en) * 1999-10-18 1999-12-22 Norgine Bv Laxative preparation
SI1255752T1 (sl) 2000-02-15 2007-12-31 Pharmacia & Upjohn Co Llc S pirolom substituirani zaviralci 2-indolinon protein kinaza
KR20080068145A (ko) * 2000-07-31 2008-07-22 셀러지 파마세우티칼스, 인크 항문직장 장애의 치료 조성물 및 방법
GB0020588D0 (en) * 2000-08-21 2000-10-11 Pfizer Ltd Treatment of wounds
AU2000270300A1 (en) * 2000-09-13 2002-03-26 Isis Innovation Limited Use of phosphodiesterase inhibitors for the treatment of anorectal disorders
AR042586A1 (es) 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
DE10118305A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Zusammensetzungen zur nasalen Applikation
DE10118306A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
JP4999255B2 (ja) 2001-07-10 2012-08-15 レイクウッド−アメディックス，インコーポレーテッド オリゴヌクレオチド含有薬理学的組成物およびその使用
WO2003022239A2 (en) * 2001-09-07 2003-03-20 Western Holdings Llc Stable water in oil aminophylline emulsions
BR0213185A (pt) 2001-10-10 2004-09-14 Sugen Inc Derivados de 3-[4-(heterociclila substituìda)-pirrol-2-ilmetilideno]2-indolinona como inibidores de cinase
JP4563679B2 (ja) * 2001-12-06 2010-10-13 デューク ユニバーシティ 形成外科における組織弁壊死の予防
WO2003075851A2 (en) * 2002-03-06 2003-09-18 Cellegy Pharmaceuticals, Inc. Compositions and methods for the treatment of anorectal disorders
US7378438B2 (en) 2002-04-19 2008-05-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
US20040147534A1 (en) * 2003-01-23 2004-07-29 Foote Mary Ann Topical composition and method for treating occlusive wounds
US6863825B2 (en) 2003-01-29 2005-03-08 Union Oil Company Of California Process for removing arsenic from aqueous streams
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
US20060147504A1 (en) * 2004-12-30 2006-07-06 Bobby Corry Feminine anti-itch cloth
WO2006080924A1 (en) * 2005-01-27 2006-08-03 C.B. Fleet Company Incorporated Feminine anti-itch gel
WO2006084913A2 (en) * 2005-02-11 2006-08-17 Nolabs Ab Device for treatment of rectal disorders, and manufacturing process for the same, involving nitric oxide
WO2007077551A2 (en) * 2005-12-30 2007-07-12 Mor Research Applications Ltd. Device and method for treating the anal sphincter
EP2404604B1 (en) * 2006-01-05 2019-02-06 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US20080045534A1 (en) * 2006-08-18 2008-02-21 Valeant Pharmaceuticals North America Derivatives of 1,3-diamino benzene as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
EP2061465B1 (en) * 2006-08-23 2013-04-10 Valeant Pharmaceuticals International Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
US8030518B2 (en) * 2006-11-28 2011-10-04 Valeant Pharmaceuticals International 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
US8066874B2 (en) 2006-12-28 2011-11-29 Molycorp Minerals, Llc Apparatus for treating a flow of an aqueous solution containing arsenic
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
US8252087B2 (en) 2007-10-31 2012-08-28 Molycorp Minerals, Llc Process and apparatus for treating a gas containing a contaminant
US8349764B2 (en) 2007-10-31 2013-01-08 Molycorp Minerals, Llc Composition for treating a fluid
WO2010146591A2 (en) 2009-06-18 2010-12-23 Rdd Pharma Ltd. Methods and devices for delivery of pharmaceutical agents within orifices of the body
US8778969B2 (en) * 2009-11-07 2014-07-15 Peter H Proctor Nitrone, nitroso, and nitroxide spintraps and spin labels and their hydroxylamines
WO2011075655A1 (en) * 2009-12-18 2011-06-23 Exodos Life Sciences Limited Partnership Methods and compositions for treating peripheral vascular disease
CN102145004B (zh) * 2010-02-09 2012-03-21 鲁南制药集团股份有限公司 己酮可可碱在制备预防或治疗功能性便秘的药物中的用途
US20130029989A1 (en) * 2010-04-15 2013-01-31 The Royal Institution For The Advancement Of Learning/Mcgill University Topical treatments for pain
US9233863B2 (en) 2011-04-13 2016-01-12 Molycorp Minerals, Llc Rare earth removal of hydrated and hydroxyl species
CA2893833A1 (en) 2011-12-16 2013-06-20 The Regents Of The University Of Michigan Digital manometry finger-mountable sensor device
CN103393690B (zh) * 2013-08-01 2016-05-11 南通大学附属医院 Katp通道开放剂在制备治疗术后疼痛药物中的应用
US10080759B2 (en) 2014-01-22 2018-09-25 Duke University Methods of treating pruritus
US10064871B2 (en) 2014-01-22 2018-09-04 Biomimetix Jv, Llc Methods of treating skin disorders
CA2941859A1 (en) 2014-03-07 2015-09-11 Molycorp Minerals, Llc Cerium (iv) oxide with exceptional arsenic removal properties
RU2595799C1 (ru) * 2015-05-14 2016-08-27 Светлана Николаевна Суслина Композиция для лечения анальных трещин в форме крема
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN112423736A (zh) * 2018-06-01 2021-02-26 塔凡塔医疗匈牙利公司 用于治疗***直肠疾病的局部氨氯地平盐

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
GB9119467D0 (en) * 1991-09-12 1991-10-23 Smithkline Beecham Corp Chemical compounds
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
ZA941027B (en) * 1993-02-16 1994-11-11 Smithkline Beecham Corp Chemical compounds
DE69429768T2 (de) * 1993-04-05 2002-09-19 Competitive Tech Inc Diagnose und behandlung von erektilen funktionsstörungen
US5948762A (en) * 1993-07-16 1999-09-07 Schering Aktiengesellschaft Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor or a nitric oxide inhibitor
WO1995006466A1 (en) * 1993-09-01 1995-03-09 Koren Laboratories Pty. Limited Treatment of anorectal disorders
KR100386525B1 (ko) * 1994-05-27 2003-08-25 셀레지 파머슈티컬스, 인코포레이티드 산화질소공여체조성물및항문질환의치료방법
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US5994294A (en) * 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
WO1998019672A1 (en) * 1996-11-01 1998-05-14 Nitromed Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
AU728889C (en) * 1996-12-23 2001-08-02 S.L.A. Pharma Ag Pharmaceutical composition for treating fecal incontinence and anal itch
CA2322168C (en) * 1998-02-27 2010-01-05 Synchroneuron, Llc Method for treating painful conditions of the anal region and compositions therefor
WO2000024745A1 (en) * 1998-10-23 2000-05-04 Pfizer Limited PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION

Also Published As

Publication number Publication date
AU2176300A (en) 2000-07-03
NO20012916L (no) 2001-08-14
BR9916162A (pt) 2001-09-04
PL348817A1 (en) 2002-06-17
IL143726A0 (en) 2002-04-21
KR20010093828A (ko) 2001-10-29
US6395736B1 (en) 2002-05-28
WO2000035434A3 (en) 2000-11-30
JP2002542147A (ja) 2002-12-10
NO20012916D0 (no) 2001-06-13
US20010012856A1 (en) 2001-08-09
AU764921B2 (en) 2003-09-04
EP1143956A3 (en) 2001-12-12
EP1143956A2 (en) 2001-10-17
CN1330539A (zh) 2002-01-09
WO2000035434A2 (en) 2000-06-22
CA2354543A1 (en) 2000-06-22
HUP0104676A2 (en) 2002-06-29
CN1526448A (zh) 2004-09-08
HUP0104676A3 (en) 2005-12-28
CN1149983C (zh) 2004-05-19

Similar Documents

Publication Publication Date Title
CZ20012113A3 (cs) Prostředky a způsoby pro léčbu onemocnění anorektální oblasti
EP1037635A4 (en) CONNECTIONS AROUND METHODS
GB2341969B (en) Editing system and editing method
GB2333234B (en) Catheter clamps and assemblies
AP9901444A0 (en) Erythrommycins and process for their preparation
PL339268A1 (en) Rapid marking-out method and system
EP0920014A4 (en) EDITING DEVICE AND EDITING METHOD
HU9904631D0 (en) Caoutchouc-powders and procedure for making them
EP1102535A4 (en) COMPOUNDS AND METHODS
IL127073A0 (en) Software translation system and method
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
AP9801175A0 (en) Quinoline and quinoline compounds useful in therapy
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
ZA95701B (en) Rivets-nails and methods for their implementation
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
HUP0101779A3 (en) Process for de-chlorinating and de-fouling waste-oil
GB9816761D0 (en) Herpesvirus preparations and their uses
EP0890599A4 (en) POLYORGANOSILOXANES AND METHOD FOR THE PRODUCTION THEREOF
HK1021117A1 (en) Candy-toy and method thereof
EP0921803A4 (en) METHOD FOR PREVENTING AND TREATING PESTVIRUS INFECTIONS AND RELATED DISEASES
PL331523A1 (en) Azolotrizines and azolopyrimidines
HK1007908A1 (en) Filter and raster operations
EP0874636A4 (en) TEA, NECESSARY AND METHOD FOR TREATING HEMORROIDS
EP0799225A4 (en) COMPOUNDS AND RELATED METHODS
AU1292000A (en) Device and method for the direct reduction of iron oxides